ClinicalTrials.Veeva

Menu

Effects and Costs of Respiratory Muscle Training in Institutionalized Elderly People

U

University of Valencia

Status

Completed

Conditions

Cardiovascular Morbidity
Respiratory Morbidity
Syndrome; Institutionalization
Muscle Weakness

Treatments

Device: Threshold® Inspiratory Muscle Trainer (treatment).

Study type

Interventional

Funder types

Other

Identifiers

NCT01759992
UV-INV-PRECOMP12-80293
H1335803152705 (Other Identifier)

Details and patient eligibility

About

The global loss of muscle mass and strength associated with aging is a cause of functional impairment and disability, particularly in the older elderly (>80 years). Respiratory function can be severely compromised if there is a decrease of respiratory (RM) strength complicated by the presence of comorbidities and physical immobility. In this context, the need for supportive services involves the need for long-term care and consequently the institutionalization.

Previous studies have shown that the increase of RM strength has positive healthy effects, such as the increase in functional capacity, the decrease in RM fatigue, the decrease of dyspnoea and the improvement of quality of life, both in healthy people and patients. Therefore, specific RM training may be regarded as a beneficial alternative to improve RM function, and thus prevent physical and clinical deterioration in this frail population.

Study hypothesis: The inspiratory muscle training (IMT) would improve respiratory muscle strength and endurance, exercise capacity and quality of life in an elderly population, who are unable to engage in general exercise conditioning.

Enrollment

45 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • People aged > 65 years
  • Barthel Index < 75 score
  • Mini-mental state examination ≥ 20 score
  • Inspiratory muscle weakness (MIP ≤ 30% predicted value)

Exclusion criteria

  • Ability to independently walk more than 14 m
  • Significant chronic cardiorespiratory diagnoses
  • Acute cardiorespiratory episode during the 2 previous months
  • Neurological, muscular, or neuromuscular problems interfering with the capacity to engage in the tests and training protocol
  • Active smokers or former smokers (< 5 years)
  • A terminal disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

45 participants in 2 patient groups

Control group
No Intervention group
Description:
Usual care
Treatment group
Experimental group
Description:
Participants will breathe against a load ≥ 50% of their baseline MIP, after which loads will increase according to the participant's tolerance across the remaining training period, using a Borg scale rating of 4 to 6 on perceived exertion as an indicator of adequate training intensity.
Treatment:
Device: Threshold® Inspiratory Muscle Trainer (treatment).

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems